Event Overview

The 15th Annual General Meeting of Alivus Life Sciences Limited was held on Tuesday, September 8, 2026 at 3:00 PM IST and concluded at 4:40 PM IST. The meeting was conducted through Video Conferencing/Other Audio Visual Means (VC/OAVM) with webcast facility provided to shareholders.

Attendance Details

  • Total shareholders on record date (September 1, 2026): 124,490
  • Shareholders present through VC/OAVM: 38
  • Promoters present: 1
  • Public shareholders present: 37
  • All directors of the company attended the AGM
  • Chairpersons of Audit Committee, Nomination and Remuneration Committee, and Stakeholders' Relationship Committee were present
  • Representatives of Statutory, Secretarial, Internal and Cost Auditors were present through VC

Management Presentations

Mr. Hiren Patel, Chairman & Non-Executive Director, presided over the meeting and highlighted the company's strong financial performance, confidence in future growth through innovation, disciplined capital allocation, sustainability initiatives, and continued value creation for shareholders.

Dr. Yasir Rawjee, Managing Director & CEO, addressed members on important milestones, FY26 performance including revenue growth, record profitability, business diversification, strong cash generation, sustainability initiatives, and continued investments in manufacturing, R&D and technology. He outlined the company's future growth strategy through the "API+" approach, expansion into advanced pharmaceutical capabilities, and commitment to creating long-term value.

Voting Process and Scrutinizer Appointment

The company provided e-voting facility through National Securities Depository Limited (NSDL) system. Remote e-voting period was from September 4, 2026 (9:00 AM IST) to September 7, 2026 (5:00 PM IST). E-voting was also available during the AGM for 30 minutes after conclusion.

Mr. Bhadresh Shah of Bhadresh Shah and Associates, Practicing Company Secretary, was appointed as Scrutinizer (resolution dated May 14, 2026) to conduct the e-voting process.

Resolutions and Voting Results

All four resolutions were passed with requisite majority:

Resolution 1: Adoption of Financial Statements

  • Type: Ordinary Resolution
  • Result: Passed with 99.9999% in favor
  • Total votes polled: 106,618,044 shares (86.8427% of outstanding shares)
  • Promoter votes: 91,896,285 shares (100% in favor)
  • Public Institutions: 14,595,099 shares (100% in favor)
  • Public Non-Institutions: 126,660 shares (99.9163% in favor)

Resolution 2: Final Dividend Declaration

  • Type: Ordinary Resolution
  • Dividend: ₹5 per equity share for FY 2025-26
  • Result: Passed with 99.9999% in favor
  • Total votes polled: 106,618,044 shares (86.8427% of outstanding shares)
  • Promoter votes: 91,896,285 shares (100% in favor)
  • Public Institutions: 14,595,099 shares (100% in favor)
  • Public Non-Institutions: 126,660 shares (99.9400% in favor)

Resolution 3: Re-appointment of Director

  • Director: Mr. Hiren Patel (DIN: 00145149)
  • Type: Ordinary Resolution
  • Result: Passed with 99.0941% in favor
  • Total votes polled: 106,618,044 shares (86.8427% of outstanding shares)
  • Promoter votes: 91,896,285 shares (100% in favor)
  • Public Institutions: 14,595,099 shares (93.3875% in favor, 6.6125% against)
  • Public Non-Institutions: 126,660 shares (99.4465% in favor, 0.5535% against)

Resolution 4: Ratification of Cost Auditor Remuneration

  • Cost Auditor: Kirit Mehta & Co. LLP for FY 2026-27
  • Type: Ordinary Resolution
  • Result: Passed with 99.9988% in favor
  • Total votes polled: 106,618,044 shares (86.8427% of outstanding shares)
  • Promoter votes: 91,896,285 shares (100% in favor)
  • Public Institutions: 14,595,099 shares (100% in favor)
  • Public Non-Institutions: 126,660 shares (98.9531% in favor, 1.0469% against)

Share Capital Structure

Total outstanding shares as of record date: 122,771,448 shares

  • Promoter and Promoter Group: 91,896,285 shares
  • Public Institutions: 15,725,917 shares
  • Public Non-Institutions: 15,149,246 shares